Am. J. Respir. Crit. Care Med., Volume 162, Number 3, September 2000, 976-980

Persistent Specific Bronchial Reactivity to Occupational Agents in Workers with Normal Nonspecific Bronchial Reactivity

CATHERINE LEMIÈRE, ANDRÉ CARTIER, JEAN-LUC MALO, and SAMUEL B. LEHRER

Department of Chest Medicine, Hôpital du Sacré-Coeur, Montréal, Canada; and Tulane University Medical Center, New Orleans, Louisiana

Specific bronchial reactivity (SBR) to common inhalants is related to the degree of nonspecific bronchial reactivity (NSBR) and to specific allergen sensitivity. We investigated 16 workers with normal NSBR who had been previously diagnosed with occupational asthma caused by high-molecular-weight agents. The agents were flour in seven workers, psyllium in five, and guar gum in four. The subjects had been removed from exposure to these agents for a mean of 5.7 (± 4.0 SD) yr, no longer showed evidence of persisting asthma, and had a normal lung function. In the present study, the workers were reexposed to the sensitizing agent by specific inhalation challenges, in the same way they were as at the time of the diagnosis, to assess their current SBR to the sensitizer. SBR was estimated as the duration of exposure that induced a 20% decrease in FEV₁. Eleven of the 16 subjects had an asthmatic reaction at the time of the study; the duration of exposure necessary to induce the asthmatic reaction was the same as that needed at the time of diagnosis (3.55 ± 0.5 min and 4.2 ± 0.7 min, respectively, p = 0.8). The decrease in specific IgE levels between the two events was much greater in the subjects who failed to react to the second challenge test (from 24.2 ± 37.5% to 3.0 ± 16.9% binding) than in those who reacted on both occasions (from 31.2 ± 27.0% to 21.6 ± 36.7% binding); however, in both groups the change was significant (p = 0.05 and 0.04, respectively). We conclude that SBR to high-molecular-weight agents persists in most cases despite a normalization of NSBR, and that this persistence is associated with a persistence of specific immunization to the agent.

This article has been cited by other articles:

				J-P. Rioux, J-L. Malo, J. L'Archeveque, K. Rabhi, and M. Labrecque Workplace-specific challenges as a contribution to the diagnosis of occupational asthma Eur. Respir. J., October 1, 2008; 32(4): 997 - 1003. [Abstract] [Full Text] [PDF]

				S. M. Tarlo, J. Balmes, R. Balkissoon, J. Beach, W. Beckett, D. Bernstein, P. D. Blanc, S. M. Brooks, C. T. Cowl, F. Daroowalla, et al. Diagnosis and Management of Work-Related Asthma: American College of Chest Physicians Consensus Statement Chest, September 1, 2008; 134(3_suppl): 1S - 41S. [Abstract] [Full Text] [PDF]

				D. Gautrin, H. Ghezzo, C. Infante-Rivard, M. Magnan, J. L'Archeveque, E. Suarthana, and J.-L. Malo Long-Term Outcomes in a Prospective Cohort of Apprentices Exposed to High-Molecular-Weight Agents Am. J. Respir. Crit. Care Med., April 15, 2008; 177(8): 871 - 879. [Abstract] [Full Text] [PDF]

				C. E. Mapp, P. Boschetto, P. Maestrelli, and L. M. Fabbri Occupational Asthma Am. J. Respir. Crit. Care Med., August 1, 2005; 172(3): 280 - 305. [Abstract] [Full Text] [PDF]

				P J Nicholson, P Cullinan, A J Newman Taylor, P S Burge, and C Boyle Evidence based guidelines for the prevention, identification, and management of occupational asthma Occup. Environ. Med., May 1, 2005; 62(5): 290 - 299. [Abstract] [Full Text] [PDF]

				K. Maghni, C. Lemiere, H. Ghezzo, W. Yuquan, and J.-L. Malo Airway Inflammation after Cessation of Exposure to Agents Causing Occupational Asthma Am. J. Respir. Crit. Care Med., February 1, 2004; 169(3): 367 - 372. [Abstract] [Full Text] [PDF]

				M. Padoan, V. Pozzato, M. Simoni, L. Zedda, G. Milan, I. Bononi, C. Piola, P. Maestrelli, P. Boschetto, and C.E. Mapp Long-term follow-up of toluene diisocyanate-induced asthma Eur. Respir. J., April 1, 2003; 21(4): 637 - 640. [Abstract] [Full Text] [PDF]

				O. Vandenplas and J-L. Malo Definitions and types of work-related asthma: a nosological approach Eur. Respir. J., April 1, 2003; 21(4): 706 - 712. [Abstract] [Full Text] [PDF]

				J. Sastre, M. Fernandez-Nieto, A. Novalbos, M. de las Heras, J. Cuesta, and S. Quirce Need for Monitoring Nonspecific Bronchial Hyperresponsiveness Before and After Isocyanate Inhalation Challenge Chest, April 1, 2003; 123(4): 1276 - 1279. [Abstract] [Full Text] [PDF]

				H. G. Ortega, D. N. Weissman, D. L. Carter, and D. Banks Use of Specific Inhalation Challenge in the Evaluation of Workers at Risk for Occupational Asthma* : A Survey of Pulmonary, Allergy, and Occupational Medicine Residency Training Programs in the United States and Canada Chest, April 1, 2002; 121(4): 1323 - 1328. [Abstract] [Full Text] [PDF]

				M. J. TOBIN Asthma, Airway Biology, and Allergic Rhinitis in AJRCCM 2000 Am. J. Respir. Crit. Care Med., November 1, 2001; 164(9): 1559 - 1580. [Full Text] [PDF]